Cancer/testis antigens and urological malignancies

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Impact of Genomics on Personalized Cancer Medicine

(2012) C. L. Arteaga et al.   CLINICAL CANCER RESEARCH

Making Personalized Cancer Medicine a Reality: Challenges and Opportunities in the Development of Biomarkers and Companion Diagnostics

(2012) D. R. Parkinson et al.   CLINICAL CANCER RESEARCH

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Expression and Immunotherapeutic Targeting of the SSX Family of Cancer-Testis Antigens in Prostate Cancer

(2011) H. A. Smith et al.   CANCER RESEARCH

Global Trends in Testicular Cancer Incidence and Mortality

(2011) Alexandre Rosen et al.   EUROPEAN UROLOGY

Therapeutic vaccination for cancer immunotherapy: Antigen selection and clinical responses

(2011) Astrid Geldmacher et al.   Human vaccines & immunotherapeutics

A majority of the cancer/testis antigens are intrinsically disordered proteins

(2011) Krithika Rajagopalan et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

mRNA Expression Signature of Gleason Grade Predicts Lethal Prostate Cancer

(2011) Kathryn L. Penney et al.   JOURNAL OF CLINICAL ONCOLOGY

Vaccines Targeting the Cancer-testis Antigen SSX-2 Elicit HLA-A2 Epitope-specific Cytolytic T Cells

(2011) Heath A. Smith et al.   JOURNAL OF IMMUNOTHERAPY

A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases

(2011) Chong Xie et al.   Journal of Translational Medicine

Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy

(2011) Takumi Shiraishi et al.   Journal of Translational Medicine

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

(2011) Jack Cuzick et al.   LANCET ONCOLOGY

The biology of cancer testis antigens: Putative function, regulation and therapeutic potential

(2011) Elisabetta Fratta et al.   Molecular Oncology

Introduction: The prevention agenda

(2011) Tiffany O'Callaghan   NATURE

Diagnosis and Management of Urothelial Carcinoma of the Bladder

(2011) Maria F. Tanaka et al.   POSTGRADUATE MEDICINE

Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer

(2011) Maurizio Chiriva-Internati et al.   PROSTATE

Treatment of Higher-Risk Myelodysplastic Syndrome

(2011) Guillermo Garcia-Manero   SEMINARS IN ONCOLOGY

A novel spliced fusion of MLL with CT45A2in a pediatric biphenotypic acute leukemia

(2010) Nuno Cerveira et al.   BMC CANCER

LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling

(2010) R Matsuda et al.   BRITISH JOURNAL OF CANCER

A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs

(2010) Jonghwan Kim et al.   CELL

Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise

(2010) Ioannis Zachos et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy

(2010) Stacey N Akers et al.   Future Oncology

MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies

(2010) Elke Schultz-Thater et al.   INTERNATIONAL JOURNAL OF CANCER

Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b

(2010) Yan-Lei Ma et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway

(2010) Shinya Hayami et al.   Molecular Cancer

Frequent MAGE Mutations in Human Melanoma

(2010) Otavia L. Caballero et al.   PLoS One

Androgen hypersensitivity in prostate cancer: Molecular perspectives on androgen deprivation therapy strategies

(2010) Ruth Foley et al.   PROSTATE

Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila

(2010) A. Janic et al.   SCIENCE

Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF

(2009) L. Fong et al.   CANCER RESEARCH

Cancer/testis (CT) antigens: Potential targets for immunotherapy

(2009) Otavia L. Caballero et al.   CANCER SCIENCE

Intrinsic Protein Disorder and Interaction Promiscuity Are Widely Associated with Dosage Sensitivity

(2009) Tanya Vavouri et al.   CELL

Regulatory T-Cell-Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma

(2009) T. Nicholaou et al.   CLINICAL CANCER RESEARCH

MAGRIT: The Largest-Ever Phase III Lung Cancer Trial Aims to Establish a Novel Tumor-Specific Approach to Therapy

(2009) Preeta Tyagi et al.   Clinical Lung Cancer

High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer

(2009) Alain Bergeron et al.   INTERNATIONAL JOURNAL OF CANCER

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

(2009) G. Draisma et al.   JNCI-Journal of the National Cancer Institute

Bladder cancer

(2009) Donald S Kaufman et al.   LANCET

Increased Expression of Androgen Receptor Coregulator MAGE-11 in Prostate Cancer by DNA Hypomethylation and Cyclic AMP

(2009) A. R. Karpf et al.   MOLECULAR CANCER RESEARCH

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC

(2009) Chad A. Glazer et al.   PLoS One

Sperm-Associated Antigen 9 Is Associated With Tumor Growth, Migration, and Invasion in Renal Cell Carcinoma

(2008) M. Garg et al.   CANCER RESEARCH

DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity

(2008) Srinivasan Yegnasubramanian et al.   CANCER RESEARCH

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

(2008) J. S. de Bono et al.   CLINICAL CANCER RESEARCH

EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

(2008) Marko Babjuk et al.   EUROPEAN UROLOGY

Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiation

(2008) Morten F. Gjerstorff et al.   HUMAN REPRODUCTION

Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical-recurrence

(2008) Raphael B. Parmigiani et al.   INTERNATIONAL JOURNAL OF CANCER

Medical Treatment of Advanced Testicular Cancer

(2008) Darren R. Feldman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

(2008) Ittai Ben-Porath et al.   NATURE GENETICS

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

(2008) L. G. Almeida et al.   NUCLEIC ACIDS RESEARCH

Selective POTE Paralogs on Chromosome 2 are Expressed in Human Embryonic Stem Cells

(2008) Tapan K. Bera et al.   STEM CELLS AND DEVELOPMENT

Population-based Assessment of Survival After Cytoreductive Nephrectomy Versus No Surgery in Patients With Metastatic Renal Cell Carcinoma

(2008) Laurent Zini et al.   UROLOGY